{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:13:44Z","timestamp":1768522424586,"version":"3.49.0"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-24-00293"],"award-info":[{"award-number":["24-24-00293"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lysosomal inhibition by different agents like chloroquine and bafilomycin A is known to sensitize some tumor cells to chemotherapeutic drugs. The mechanism and signaling pathways are still under investigation. We showed that chloroquine sensitized tumor cells (MCF7, SKBR3, HCT116) to drugs (carboplatin, cisplatin) treatment. Treatment with the combination of platinum drugs and chloroquine resulted in the increased rate of apoptosis compared with single agent treatment. Moreover, we demonstrated the inhibition of the resumption of cell proliferation after cell cycle arrest induced by drugs treatment. Cells treated with the combination of carboplatin (or cisplatin) and chloroquine demonstrated the significant increase in Chk1 protein phosphorylation (Ser345), which together with S-phase increase indicated the induction of replication stress compared to cells treated with carboplatin (or cisplatin) alone. The rescue experiment performed by supplementation the combination of carboplatin and chloroquine with deoxyribonucleotides (dNTPs) demonstrated the reverse of inhibition of cells\u2019 re-proliferation after cell cycle arrest caused by this combination of drugs. Treatment with carboplatin and ATR inhibitor (ceralasertib) greatly increased the level of phospho-Chk1 and induced the replication stress, which is consistent with previous studies. Supplementation of the above drug combination with chloroquine further increased Chk1 phosphorylation and decreased the number of cells able to re-proliferate after the induced stress. Here, we also demonstrated that dNTPs\u2019 supplementation reversed the effect of chloroquine. Similar results were obtained with the combination of carboplatin and Chk1 inhibitor (prexasertib). It was also demonstrated that chloroquine could potentiate the effect of single agent treatment of tumor cells with ATRi\/Chk1i in MCF7 cells. Here, we proposed a novel explanation for the chloroquine ability to potentiate the effect of chemotherapy. The results clearly demonstrated that stress induced by chloroquine is due to its ability to increase the replication stress and to reduce the availability of nucleotides.<\/jats:p>","DOI":"10.3390\/ijms27020856","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:26:36Z","timestamp":1768465596000},"page":"856","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chloroquine Potentiates the Chemotherapeutic Effect of Carboplatin and ATR\/Chk1 Inhibitors by Increasing the Replication Stress"],"prefix":"10.3390","volume":"27","author":[{"given":"Maria","family":"Zamkova","sequence":"first","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"},{"name":"Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda","family":"Persiyantseva","sequence":"additional","affiliation":[{"name":"Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Vikhrova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"},{"name":"Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-8421","authenticated-orcid":false,"given":"Dmitriy","family":"Kazansky","sequence":"additional","affiliation":[{"name":"Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1200\/JCO.2007.11.9362","article-title":"Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment","volume":"26","author":"Albain","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Homayouni","year":"2017","journal-title":"Oncotarget"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tips.2004.12.002","article-title":"Overcoming limitations of natural anticancer drugs by combining with artificial agents","volume":"26","author":"Blagosklonny","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2009.09.004","article-title":"Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance","volume":"141","author":"Khdair","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: Therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent Drug Action in Combination Therapy: Implications for Precision Oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jin, Z., Zhao-Xia, L., Fan-Ke, P., Wen-Juan, Z., Min-Li, W., and Han-Yi, Z. (2024). Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1327502"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/cas.13455","article-title":"DNA replication stress and cancer chemotherapy","volume":"109","author":"Kitao","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nickoloff, J.A. (2022). Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy. Molecules, 27.","DOI":"10.3390\/molecules27154736"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.radonc.2017.09.043","article-title":"ATR\/CHK1 inhibitors and cancer therapy","volume":"126","author":"Qiu","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1158\/1535-7163.MCT-14-1037","article-title":"LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms","volume":"14","author":"King","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cllc.2021.04.005","article-title":"A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer","volume":"22","author":"Byers","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"ref_13","first-page":"1013-e1824","article-title":"A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer","volume":"25","author":"Karzai","year":"2020","journal-title":"Oncologist"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/1078-0432.CCR-21-1032","article-title":"Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","article-title":"Activity of a new antimalarial agent, chloroquine (SN 7618): Statement approved by the Board for coordination of malarial studies","volume":"130","author":"Loeb","year":"1946","journal-title":"J. Am. Med. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Niemann, B., Puleo, A., Stout, C., Markel, J., and Boone, B.A. (2022). Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122551"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Agalakova, N.I. (2024). Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020945"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e3014","DOI":"10.1038\/cddis.2017.416","article-title":"Lysosomotropism depends on glucose: A chloroquine resistance mechanism","volume":"8","author":"Gallagher","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/auto.8.2.18554","article-title":"Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy","volume":"8","author":"Maycotte","year":"2012","journal-title":"Autophagy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2020.1817479","article-title":"Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose","volume":"59","author":"Doyno","year":"2021","journal-title":"Clin. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: A double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1878-0261.12179","article-title":"CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species","volume":"12","author":"Fu","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1073\/pnas.1812410116","article-title":"Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion","volume":"116","author":"Elliott","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","first-page":"3039","article-title":"Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells","volume":"8","author":"Villalan","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1016\/j.bmc.2005.12.035","article-title":"Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells","volume":"14","author":"Fan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/0008-5472.CAN-18-3631","article-title":"Exploiting DNA Replication Stress for Cancer Treatment","volume":"79","author":"Ubhi","year":"2019","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molcel.2005.07.019","article-title":"Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway","volume":"19","author":"Zhang","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.174.4.881","article-title":"Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: Studies of a pathogenic mycobacterium and a nonpathogenic yeast","volume":"174","author":"Hart","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2011.03.044","article-title":"Nucleotide deficiency promotes genomic instability in early stages of cancer development","volume":"145","author":"Bester","year":"2011","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","article-title":"Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD","volume":"57","author":"Donne","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"zcac036","DOI":"10.1093\/narcan\/zcac036","article-title":"Multiple-low-dose therapy: Effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors","volume":"4","author":"Golder","year":"2022","journal-title":"NAR Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1128\/MCB.00447-06","article-title":"Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit","volume":"26","author":"Ryan","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1158\/1078-0432.CCR-10-3082","article-title":"Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition","volume":"17","author":"Parsels","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110060","DOI":"10.1016\/j.celrep.2021.110060","article-title":"CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment","volume":"37","author":"Klomp","year":"2021","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Baraka, B., Ponda, D.J., Hanna, J., Gomez, D., Aithal, G., and Arora, A. (2025). Efficacy and Toxicity Profile of Carboplatin\/Gemcitabine Chemotherapy in Locally Advanced or Metastatic Biliary Tract Cancer: A Single UK Centre Experience. Cancers, 17.","DOI":"10.3390\/cancers17193102"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Duarte, D., and Vale, N. (2020). New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells. Biomolecules, 10.","DOI":"10.3390\/biom10121623"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41419-020-03242-x","article-title":"Chloroquine reverses chemoresistance via upregulation of p21(WAF1\/CIP1) and autophagy inhibition in ovarian cancer","volume":"11","author":"Hwang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/s41467-020-16952-9","article-title":"Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours","volume":"11","author":"Nadal","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.18632\/oncotarget.6364","article-title":"A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase","volume":"7","author":"Sakurikar","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40778","DOI":"10.1038\/srep40778","article-title":"Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage","volume":"7","author":"Massey","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhang, J., Chan, D.W., and Lin, S.Y. (2022). Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112775"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2018.03.005","article-title":"Targeting the replication stress response in cancer","volume":"188","author":"Forment","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115605","DOI":"10.1016\/j.celrep.2025.115605","article-title":"The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy","volume":"44","author":"Fu","year":"2025","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2023.03.048","article-title":"Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes","volume":"656","author":"Bano","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.21873\/anticanres.15899","article-title":"Effect of Chloroquine on Doxorubicin-induced Apoptosis in A549 Cells","volume":"42","author":"Sato","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2014.9.FOCUS14504","article-title":"Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy","volume":"37","author":"Golden","year":"2014","journal-title":"Neurosurg. Focus"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/856\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:35:51Z","timestamp":1768466151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020856"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020856","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}